SECTRA (SECT) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
1 Apr, 2026Executive summary
Net sales increased by 8% to SEK 2.5 billion for the nine-month period, with profit per share up 18% to SEK 2.5 per share.
Achieved highest customer satisfaction in the industry for the thirteenth consecutive year, with strong order bookings and continued leadership in enterprise imaging solutions.
Cloud recurring revenue grew 58% year-over-year, now a significant driver of growth and profitability.
Operating profit rose 21% to SEK 502 million, with a margin of 20%, excluding last year's patent settlement.
Transition to service-based and cloud sales is progressing, driving recurring revenue growth and long-term value.
Financial highlights
Nine-month net sales rose 7.9% year-over-year to SEK 2,508.5 million; recurring revenue up 18.5% to SEK 1,769.1 million.
Cloud recurring revenue increased 57.5% to SEK 641.1 million; recurring revenue now 70.5% of total sales.
Operating profit (excluding patent settlement) up 21.1% to SEK 501.5 million; operating margin 20.0%.
Cash flow from operations reached SEK 578 million year-to-date, with SEK 418 million generated in Q3.
Imaging IT Solutions sales up 10% to nearly SEK 2.2 billion; Business Innovation sales up 25%.
Outlook and guidance
Large contract rollouts are underway, with more hospitals going live over the next year.
High costs expected to persist in the coming quarters as implementations ramp up.
Delays in Secure Communications expected to impact results for the remainder of the fiscal year; normalization anticipated next year.
Autonomous AI acquisition (Oxipit) expected to have no material financial impact this year, minor next year.
Stable base of long-term recurring revenue and very low churn rate (0.5%).
Latest events from SECTRA
- Cloud recurring revenue surged 55.9% and operating profit rose 13.6% year-over-year.SECT
Q4 23/2431 Jan 2026 - Q1 sales up 24%, operating profit up 44%, with strong recurring and cloud revenue growth.SECT
Q1 24/2522 Jan 2026 - Record order intake and recurring revenue growth offset by lower profit during cloud transition.SECT
Q2 24/2511 Jan 2026 - Sales up 13%, cloud recurring revenue up 44%, and profit boosted by a patent settlement.SECT
Q3 24/2521 Dec 2025 - Cloud and recurring revenue growth drive profit, but upfront costs pressure margins.SECT
Q2 25/2612 Dec 2025 - SaaS, AI, and integrated diagnostics drive global growth and leadership in medical IT.SECT
CMD 20251 Dec 2025 - Record order intake and recurring revenue growth drive profitability and cash flow.SECT
Q4 24/2511 Nov 2025 - Order bookings and recurring revenue surged, driven by SaaS and US/Canada growth.SECT
Q1 25/264 Sep 2025